Develop innovative, cutting-edge antitumor therapies targeting tumor- associated glycans, providing novel alternatives for patients with unmet therapeutic needs.
Valeria Segatori, PhD
Esp. Biotecnología e
Inmunooncología
Mariano Gabri, PhD
Esp. Glicobiología y Biología tumoral
Mateo Peyloubet
Esp. Negocios MBA Udesa
We specialize in the development of novel glycanmimesis technologies that facilitate the detection and targeting of tumor cells.
Our team produces high-quality active ingredients for pharmaceutical applications, improving the efficacy of cancer therapeutics.
We collaborate with academic and industry partners to enhance research initiatives focused on cancer treatment and immunology.
Glycomime provides comprehensive support for clinical trials, ensuring our innovations are rigorously tested before reaching the market.
Our specialists guide the regulatory approval process, ensuring compliance and expedited pathways to market for our developments.
We offer tailored research services to meet the unique needs of our partners within the biotech and pharmaceutical industries.
Innovative Glycanmimesis Solutions for a Healthier Future